NCT05431868

Brief Summary

This prospective cohort study enrolled patients with implantation of a trifocal IOL. Only one eye of each patient was enrolled. Eyes were devided into three groups according the axial length (AL), including the short AL group, the control group and the long AL group. Manifest refraction, uncorrected and distance-corrected visual acuity at different distances, contrast sensitivity, aberrations and IOL decentration were measured three months after surgery. Spectacle independence, adverse photic phenomena, overall satisfaction and life quality were assessed with a questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

2.1 years

First QC Date

June 20, 2022

Last Update Submit

June 20, 2022

Conditions

Keywords

CataractPresbyopiaIntraocular LensAxial LengthSatisfaction

Outcome Measures

Primary Outcomes (7)

  • Refractive Outcomes

    Manifest refraction was measured.

    Three months after surgery.

  • Visual Acuity at Different Distances

    Uncorrected and corrected distance (5 m) visual acuity (UDVA, CDVA), uncorrected and distance-corrected intermediate (80 cm) and near (40 cm) visual acuity (UIVA, DCIVA, UNVA and DCNVA) were measured.

    Three months after surgery.

  • Defocus Curve

    The defocus curve was measured with the additional spherical diopters from +2.00 D to -4.00 D in 0.50 D steps.

    Three months after surgery.

  • Contrast Sensitivity and Aberrations

    Using the OPTEC 6500 Vision Tester (Stereo Optical Co. Inc, Chicago, USA), the contrast sensitivity was conducted under four conditions, including photopic(85 cd/m2), mesopic(3 cd/m2), photopic with glare and mesopic with glare. Besides, there are five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree \[cpd\]) under every condition.

    Three months after surgery.

  • IOL decentration

    OPD Scan-III (NIDEK, Inc.) can automatically recognize and locate the edge of the pupil and measure its position relative to the optic axis. After pupil dilation, the IOL decentration was measured through adjusting the edge of the pupil to the edge of the lens manually.

    Three months after surgery.

  • Subjective Satisfaction

    The subjective satisfaction was assessed by a self-made questionnaire, which evaluated the spectacle independence at different distances, the incidence of several adverse photic phenomena including glare, halo and starburst, and the overall satisfaction.

    Three months after surgery.

  • Life Quality

    The life quality after surgery was assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Chinese.

    Three months after surgery.

Study Arms (3)

the short AL group

Eyes with AL less than 22.50 mm were devided into the short AL group.

Other: AT LISA tri 839MP (Carl Zeiss Meditec AG)

the control group

Eyes with AL between 22.50 to 25.50 mm were devided into the control group.

Other: AT LISA tri 839MP (Carl Zeiss Meditec AG)

the long AL group

Eyes with AL more than 25.50 mm were devided into the long AL group.

Other: AT LISA tri 839MP (Carl Zeiss Meditec AG)

Interventions

This prospective cohort study collected data of patients who underwent bilateral or unilateral cataract surgery with the AT LISA tri 839MP implantation.

the control groupthe long AL groupthe short AL group

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This prospective cohort study collected data of patients who underwent bilateral or unilateral cataract surgery with the AT LISA tri 839MP implantation at the Department of Ophthalmology, Peking University Third Hospital, Beijing, China.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

MeSH Terms

Conditions

CataractPresbyopiaMyopiaPersonal Satisfaction

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive ErrorsBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2022

First Posted

June 24, 2022

Study Start

January 1, 2019

Primary Completion

January 31, 2021

Study Completion

December 31, 2021

Last Updated

June 24, 2022

Record last verified: 2022-06

Locations